Clinical trial
Treatment Patterns and 6 and 12-Month Effectiveness of Tofacitinib in the Corrona Rheumatoid Arthritis Registry
NCT04721808 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment Patterns and 6 and 12-Month Effectiveness of Tofacitinib in the Corrona Rheumatoid Arthritis Registry
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 22, 2021
- Completion date
- November 24, 2021
- Enrollment
- 1,712 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.